{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:32:18Z","timestamp":1792409538579,"version":"4.4.0"},"reference-count":52,"publisher":"Xia & He Publishing","issue":"3","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.xiahepublishing.com"],"crossmark-restriction":false},"short-container-title":["J Clin Transl Hepatol"],"published-print":{"date-parts":[[2022,6,28]]},"DOI":"10.14218\/jcth.2021.00271","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T02:31:18Z","timestamp":1641781878000},"page":"543-552","update-policy":"https:\/\/doi.org\/10.14218\/crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Statin-induced Liver Injury Patterns: A Clinical Review"],"prefix":"10.14218","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7739-7689","authenticated-orcid":false,"given":"Leon D.","family":"Averbukh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6867-7569","authenticated-orcid":false,"given":"Alla","family":"Turshudzhyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"issue":"10","key":"key20220110023113_JCTH-D-21-00271-b1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11883-019-0800-z","article-title":"Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence","volume":"21","author":"Lee","year":"2019","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"key20220110023113_JCTH-D-21-00271-b2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11936-009-0027-3","article-title":"Management of the statin-intolerant patient","volume":"11","author":"Smiley III","year":"2009","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"7","key":"key20220110023113_JCTH-D-21-00271-b3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cld.2007.06.010","article-title":"Lipid-lowering agents that cause drug-induced hepatotoxicity","volume":"11","author":"Bhardwaj","year":"2007","journal-title":"Clin Liver Dis"},{"issue":"1","key":"key20220110023113_JCTH-D-21-00271-b4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/0975-7406.171699","article-title":"Statins and its hepatic effects: Newer data, implications, and changing recommendations","volume":"8","author":"Jose","year":"2016","journal-title":"J Pharm Bioallied Sci"},{"issue":"9","key":"key20220110023113_JCTH-D-21-00271-b5","first-page":"605","article-title":"Statins and liver injury","volume":"9","author":"Thapar","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"key20220110023113_JCTH-D-21-00271-b6","first-page":"711","article-title":"Considerations for safe use of statins: Liver enzyme abnormalities and muscle toxicity","volume":"83","author":"Gillett","year":"2011","journal-title":"Am Fam Physician"},{"issue":"2","key":"key20220110023113_JCTH-D-21-00271-b7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2011.07.023","article-title":"Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing","volume":"56","author":"Bj\u00f6rnsson","year":"2012","journal-title":"J Hepatol"},{"issue":"6","key":"key20220110023113_JCTH-D-21-00271-b8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1517\/14740338.6.6.673","article-title":"Idiosyncratic drug-induced liver injury: an overview","volume":"6","author":"Hussaini","year":"2007","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"key20220110023113_JCTH-D-21-00271-b9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0034-1375953","article-title":"Epidemiology and risk factors for idiosyncratic drug-induced liver injury","volume":"34","author":"Bj\u00f6rnsson","year":"2014","journal-title":"Semin Liver Dis"},{"key":"key20220110023113_JCTH-D-21-00271-b10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.12659\/AJCR.914707","article-title":"Statin-Induced Rhabdomyolysis, Acute Kidney Injury, and Hepatitis Leading to Death","volume":"20","author":"Mohamed","year":"2019","journal-title":"Am J Case Rep"},{"issue":"6","key":"key20220110023113_JCTH-D-21-00271-b11","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/jdi.13271","article-title":"Statin-induced autoimmune hepatitis in patients with type 1 diabetes: A report of two cases and literature review","volume":"11","author":"Kawasaki","year":"2020","journal-title":"J Diabetes Investig"},{"issue":"3","key":"key20220110023113_JCTH-D-21-00271-b12","first-page":"e7299","article-title":"Autoimmune-like Drug-induced Liver Injury Caused by Atorvastatin and Demonstration of the Safety Profile of Pravastatin: A Case Report and Literature Review","volume":"12","author":"Khan","year":"2020","journal-title":"Cureus"},{"issue":"5","key":"key20220110023113_JCTH-D-21-00271-b13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.gastrohep.2017.05.010","article-title":"Autoimmune Hepatitis (Immune-Mediated Liver Injury) Induced By Rosuvastatin","volume":"41","author":"S\u00e1nchez","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"key20220110023113_JCTH-D-21-00271-b14","first-page":"23247096211014050","article-title":"Severe Liver Injury Associated With High-Dose Atorvastatin Therapy","volume":"9","author":"Saha","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"5","key":"key20220110023113_JCTH-D-21-00271-b15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.14740\/gr1212","article-title":"Acute Liver Injury in a Patient Treated With Rosuvastatin: A Rare Adverse Effect","volume":"12","author":"Shah","year":"2019","journal-title":"Gastroenterology Res"},{"issue":"3","key":"key20220110023113_JCTH-D-21-00271-b16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4103\/0253-7613.132197","article-title":"Acute hepatic injury with atorvastatin: an unusual occurrence","volume":"46","author":"Vishwakarma","year":"2014","journal-title":"Indian J Pharmacol"},{"issue":"12","key":"key20220110023113_JCTH-D-21-00271-b17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.5414\/CPP48798","article-title":"Atorvastatin-induced acute elevation of hepatic enzymes and the absence of cross-toxicity of pravastatin","volume":"48","author":"Liu","year":"2010","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"8","key":"key20220110023113_JCTH-D-21-00271-b18","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3748\/wjg.v13.i8.1286","article-title":"Liver toxicity of rosuvastatin therapy","volume":"13","author":"Famularo","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"7","key":"key20220110023113_JCTH-D-21-00271-b19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/cid\/ciw448","article-title":"Gender Differences in Statin Prescription Rate Among Patients Living With HIV and Hepatitis C Virus","volume":"63","author":"Al-Kindi","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"key20220110023113_JCTH-D-21-00271-b20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00228-015-1980-2","article-title":"Gender differences in statin prescription rates, adequacy of dosing, and association of statin therapy with outcome after heart failure hospitalization: a retrospective analysis in a community setting","volume":"72","author":"Ballo","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"key20220110023113_JCTH-D-21-00271-b21","unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Roussel Uclaf Causality Assessment Method (RUCAM) in Drug Induced Liver Injury. [Updated 2019 May 4]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548272\/"},{"issue":"4","key":"key20220110023113_JCTH-D-21-00271-b22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.14218\/JCTH.2018.00039","article-title":"Role of Biologics in the Development of Autoimmune Hepatitis: A Review","volume":"6","author":"Averbukh","year":"2018","journal-title":"J Clin Transl Hepatol"},{"issue":"6","key":"key20220110023113_JCTH-D-21-00271-b23","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bj\u00f6rnsson","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"key20220110023113_JCTH-D-21-00271-b24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1189\/jlb.0205064","article-title":"Differential effects of statins on relevant functions of human monocyte-derived dendritic cells","volume":"79","author":"Yilmaz","year":"2006","journal-title":"J Leukoc Biol"},{"key":"key20220110023113_JCTH-D-21-00271-b25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molimm.2018.05.005","article-title":"TLR2\/4 ligand-amplified liver inflammation promotes initiation of autoimmune hepatitis due to sustained IL-6\/IL-12\/IL-4\/IL-25 expression","volume":"99","author":"Chi","year":"2018","journal-title":"Mol Immunol"},{"issue":"4","key":"key20220110023113_JCTH-D-21-00271-b26","first-page":"160","article-title":"Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease","volume":"6","author":"Castiella","journal-title":"World J Hepatol 2014;27"},{"issue":"42","key":"key20220110023113_JCTH-D-21-00271-b27","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.2174\/0929867325666180327095441","article-title":"Liver and Statins: A Critical Appraisal of the Evidence","volume":"25","author":"Licata","year":"2018","journal-title":"Curr Med Chem"},{"issue":"10","key":"key20220110023113_JCTH-D-21-00271-b28","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.cgh.2017.04.039","article-title":"Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis","volume":"15","author":"Kim","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"15","key":"key20220110023113_JCTH-D-21-00271-b29","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1001\/archinte.159.15.1811-a","article-title":"Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus. Grupo Lupus Virgen de las Nieves","volume":"159","author":"Jim\u00e9nez-Alonso","year":"1999","journal-title":"Arch Intern Med"},{"issue":"5","key":"key20220110023113_JCTH-D-21-00271-b30","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1572-0241.1999.01091.x","article-title":"Acute cholestatic hepatitis associated with pravastatin","volume":"94","author":"Hartleb","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"key20220110023113_JCTH-D-21-00271-b31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-8278(02)00092-2","article-title":"Acute cholestatic hepatitis after reinitiating treatment with atorvastatin","volume":"37","author":"Ridruejo","year":"2002","journal-title":"J Hepatol"},{"issue":"6","key":"key20220110023113_JCTH-D-21-00271-b32","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0168-8278(03)00464-1","article-title":"Fatal liver failure with atorvastatin","volume":"39","author":"Perger","year":"2003","journal-title":"J Hepatol"},{"issue":"1","key":"key20220110023113_JCTH-D-21-00271-b33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1157\/13083248","article-title":"Hepatitis colest\u00e1sica aguda tras la reintroducci\u00f3n de atorvastatina [Acute cholestatic hepatitis after atorvastatin reintroduction]","volume":"29","author":"de Castro","year":"2006","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"key20220110023113_JCTH-D-21-00271-b34","first-page":"29","article-title":"Cholestatic hepatitis induced by atorvastastin: a Case Report","volume":"1","author":"Vergura","year":"2007","journal-title":"Italian Journal of Medicine"},{"key":"key20220110023113_JCTH-D-21-00271-b35","article-title":"Ferrell LD, Kakar S, editors","journal-title":"Liver Pathology. 1st ed. Demos Medical Publishing 2011"},{"issue":"9","key":"key20220110023113_JCTH-D-21-00271-b36","first-page":"603","article-title":"Statin-induced cholestatic hepatitis: confirmed on rechallenge","volume":"9","author":"Kerzner","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"22","key":"key20220110023113_JCTH-D-21-00271-b37","first-page":"e931418","article-title":"Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury","volume":"12","author":"Alanazi","year":"2021","journal-title":"Am J Case Rep"},{"issue":"40","key":"key20220110023113_JCTH-D-21-00271-b38","doi-asserted-by":"crossref","first-page":"e22572","DOI":"10.1097\/MD.0000000000022572","article-title":"Atorvastatin associated with gamma glutamyl transpeptidase elevation in a hyperlipidemia patient: A case report and literature review","volume":"99","author":"Xu","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"18","key":"key20220110023113_JCTH-D-21-00271-b39","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.2169\/internalmedicine.2708-19","article-title":"Detection of Anti-mitochondrial Antibodies Accompanied by Drug-induced Hepatic Injury due to Atorvastatin","volume":"58","author":"Kuniyoshi","year":"2019","journal-title":"Intern Med"},{"issue":"4","key":"key20220110023113_JCTH-D-21-00271-b40","first-page":"246","article-title":"Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry","volume":"106","author":"Perdices","year":"2014","journal-title":"Rev Esp Enferm Dig"},{"issue":"2","key":"key20220110023113_JCTH-D-21-00271-b41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.27157","article-title":"Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network","volume":"60","author":"Russo","year":"2014","journal-title":"Hepatology"},{"issue":"177","key":"key20220110023113_JCTH-D-21-00271-b42","first-page":"1","article-title":"Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012","author":"Gu","year":"2014","journal-title":"NCHS Data Brief"},{"issue":"2","key":"key20220110023113_JCTH-D-21-00271-b43","first-page":"113","article-title":"Drug-induced cholestasis","volume":"12","author":"Chitturi","year":"2001","journal-title":"Semin Gastrointest Dis"},{"issue":"3","key":"key20220110023113_JCTH-D-21-00271-b44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/11531660-000000000-00000","article-title":"Atorvastatin-induced prolonged cholestasis with bile duct damage","volume":"30","author":"Merli","year":"2010","journal-title":"Clin Drug Investig"},{"issue":"10","key":"key20220110023113_JCTH-D-21-00271-b45","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1440-1746.2011.06836.x","article-title":"Effects of statins on cholestasis: good, bad or indifferent?","volume":"26","author":"Kuver","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"key20220110023113_JCTH-D-21-00271-b46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","article-title":"Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism","volume":"8","author":"Golomb","year":"2008","journal-title":"Am J Cardiovasc Drugs"},{"issue":"4","key":"key20220110023113_JCTH-D-21-00271-b47","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1515\/aiht-2017-68-2994","article-title":"Hepatotoxicity associated with statins","volume":"68","author":"Karahalil","year":"2017","journal-title":"Arh Hig Rada Toksikol"},{"key":"key20220110023113_JCTH-D-21-00271-b48","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.71610","article-title":"Mitochondrial oxidative stress and calcium-dependent permeability transition are key players in the mechanisms of statins-associated side effects","author":"Busanello","year":"2018","journal-title":"Mitochondrial Diseases"},{"issue":"8","key":"key20220110023113_JCTH-D-21-00271-b49","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00004836-200609000-00018","article-title":"Autoimmune hepatitis triggered by statins","volume":"40","author":"Alla","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"42","key":"key20220110023113_JCTH-D-21-00271-b50","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.2174\/0929867325666180327095441","article-title":"Liver and Statins: A Critical Appraisal of the Evidence","volume":"25","author":"Licata","year":"2018","journal-title":"Curr Med Chem"},{"issue":"10","key":"key20220110023113_JCTH-D-21-00271-b51","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.cgh.2017.04.039","article-title":"Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis","volume":"15","author":"Kim","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"key20220110023113_JCTH-D-21-00271-b52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/1751-2980.12697","article-title":"Corticosteroid therapy in drug-induced liver injury: Pros and cons","volume":"20","author":"Hu","year":"2019","journal-title":"J Dig Dis"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:20:55Z","timestamp":1783707655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,5,12]]},"published-print":{"date-parts":[[2022,6,28]]}},"alternative-id":["10.14218\/JCTH.2021.00271"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2021.00271","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]}}}